Skip to main content
SpringerLink
Log in

Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder

  • Article
  • Published:
Pathology Oncology Research

Abstract

The progression of bladder cancer to invasive disease is highly dependent on its ability to penetrate basement membrane of urothelium. Studies on diabetic nephropathy have shown a reduction in proteoglycan content of the glomerular basement membrane. Based on the well-known fact that proteoglycans are one of the main components of basement membrane and extracellular matrix we assessed the relationship between diabetes mellitus, bladder cancer incidence and its behavior. These studies include 252 patients with microscopically confirmed transitional cell carcinoma of bladder, and 549 patients with other urological disorders who served as controls. The prevalence of diabetes mellitus in each group was assessed. The group of patients suffering from transitional cell carcinoma was divided according to etiological risk factors such as cigarette smoking, diabetes and patients that were non-smokers and did not suffer from diabetes mellitus. We assessed the features of bladder cancer behavior in each group. Logistic regression model estimation for statistical analysis was used, with transitional cell carcinoma as a dependent binary variable and age, sexes smoking and diabetes as independent variables. Statistical significance was considered at two levels: p <-0.001 and p <-0.05. Odds ratio (OR) adjusted to age, sex, cigarette smoking, diabetes mellitus and 95% Confidence Interval (CI) were calculated for TCC. In the TCC group 22.2% of the patients suffered from diabetes mellitus. In the control group 10.38% suffered from diabetes mellitus. Logistic regression analysis, OR and 95% CI showed a statistically significant relationship between diabetes and TCC. These data are comparable only with smoking (OR -2.3; 95% CI -1.6 –3.5 and OR-1.58; 95% CI -1.08 –2.4 correspondingly). Based on these data we suggest that diabetes mellitus may be considered an etiological risk factor for bladder cancer development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cotran RS, Kumar V, Robbins SL, et al: Pathologic basis of disease, 5th ed, WB Saunders Co, Philadelphia, Pennsylvania, 1994.

    Google Scholar 

  2. Hayes RB, Friedell GH, Zahm SH, et al: Are the known bladder cancer risk factors associated with more advanced bladder cancer? Cancer Causes Control 4:157–162, 1993.

    Article  PubMed  CAS  Google Scholar 

  3. Schulte PA, Ringen K, Hemstreet GP, et al: Risk factors for bladder cancer in a cohort exposed to aromatic amines. Cancer 58:21–56, 1986.

    Article  Google Scholar 

  4. Silverman DT, Hartge P, Morrison AS, et al: Epidemiology of bladder cancer. Hematol Oncol Clin North Am 6:1–30, 1992.

    PubMed  CAS  Google Scholar 

  5. Wilkens LR, Kadir MM, Kolonel LN, et al: Risk factors for lower urinary tract cancer: the role of total fluid consumption, nitrites and nitrosamines, and selected foods. Cancer Epidemiol Biomarkers Prev 5:161–166, 1996.

    PubMed  CAS  Google Scholar 

  6. Asten P, Barrett J, Symmons D: Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol 26:1705–1714, 1999.

    PubMed  CAS  Google Scholar 

  7. Liu BC, Liotta LA: Biochemistry of bladder cancer invasion and metastasis. Urol Clin North Am 19:621–627, 1992.

    PubMed  CAS  Google Scholar 

  8. Jackson RL, Buch SJ, Cardin AD: Glycosaminogycans: molecular properties, protein interaction, and role in physiological processes. Physiol Rev 71:481–539, 1991.

    PubMed  CAS  Google Scholar 

  9. Ruoslahti E, Yamaguchi Y: Proteoglycans as modulators of growth factor activities. Cell 64:867–869, 1991.

    Article  PubMed  CAS  Google Scholar 

  10. Vlodavsky I, Eldor A, Haimovitz-Friedman A, et al: Expression of heparanase by platelets and circulating cells of immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12:112–127, 1992.

    PubMed  CAS  Google Scholar 

  11. Nakajima M, Irimura T, Nicolson GL: Heparanases and tumor metastasis. J Cell Biochem 36:157–167, 1988.

    Article  PubMed  CAS  Google Scholar 

  12. Timar J, Diczhazi C, Bartha I, et al: Modulation of heparan-sulphat/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells. Int J Cancer 62:755–761, 1995

    Article  PubMed  CAS  Google Scholar 

  13. Tamsma JT, van den Born J, Bruijn JA, et al: Expression of glomerular extra cellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313–320, 1994.

    Article  PubMed  CAS  Google Scholar 

  14. Uehling DT, Kelly E, Hopkins WJ, et al: Urinary glycosaminoglycan levels following induced cystitis in monkeys. J Urology 139:1103–1105, 1988.

    CAS  Google Scholar 

  15. Parsons CL, Boychuk S, Hurst R, et al: Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139–142, 1990.

    PubMed  CAS  Google Scholar 

  16. Bodenstab W, Kaufman J, Parsons CL: Inactivation of antiadherence effect of bladder surface glycosaminoglycans by a complete urinary carcinogen (N-Methyl — N — Nitrosourea). J Urol 129:200–201, 1983.

    PubMed  CAS  Google Scholar 

  17. Messing EM, Hanson P, Ulrich P, et al: Epidermal growth factor interaction with normal and malignant urothelium: in vivo and in situ studies. J Urol 138:1329–1335, 1987.

    PubMed  CAS  Google Scholar 

  18. Messing EM: Clinical implication of the expression of epidermal growth factor in human transitional cell carcinoma. Cancer Res 50:2530–2537, 1990.

    PubMed  CAS  Google Scholar 

  19. Kristensen JK, Lose G, Lund F, Nexo E: Epidermal growth factor in urine from patients with urinary bladder tumors. Eur Urol 14:313–314, 1988.

    PubMed  CAS  Google Scholar 

  20. Lokeshwar VB, Lokeshwar VB, Young MJ, et al: Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. Cancer Res 59:4464–4470, 1999.

    PubMed  CAS  Google Scholar 

  21. Attia N, Caprio S, Jones TW, et al: Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes. J Clin Endocrinol Metab 84:2324–2328, 1999.

    Article  PubMed  CAS  Google Scholar 

  22. Butler AA, Blakesley VA, Poulaki V, et al: Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression. Cancer Res 58:3021–3027, 1998.

    PubMed  CAS  Google Scholar 

  23. Kamel HK, Rodriguez-Saldana J, Flaherty JH, et al: Diabetes mellitus among ethnic seniors: contrasts with diabetes in whites. Clin Geriatr Med 15:265–278, 1999.

    PubMed  CAS  Google Scholar 

  24. Sinclair AJ: Diabetes in the elderly: A perspective from the United Kingdom. Clin Geriatr Med 15:225–37, 1999.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Barzilay Medical Center, Askelon

    Sergey Kravchick & Shmuel Cytron

  2. Department of Pathology, Hasharon Hospital, Petah Tikva, Israel

    Rivka Gal, Yona Weissman & Rumelia Koren

  3. Epidemiology Unit, Barzilay Medical Center, Askelon

    Ronit Peled

  4. Department of Urology, Hasharon Hospital, Petah Tikva, Israel

    Eliahu Mukamel

Authors
  1. Sergey Kravchick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rivka Gal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shmuel Cytron
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ronit Peled
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yona Weissman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eliahu Mukamel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rumelia Koren
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kravchick, S., Gal, R., Cytron, S. et al. Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder. Pathol. Oncol. Res. 7, 56–59 (2001). https://doi.org/10.1007/BF03032606

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03032606

Keywords

Search

Navigation